{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:36:49Z","timestamp":1782311809770,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cholesterol is an essential component of membranes, which is acquired by cells via receptor-mediated endocytosis of lipoproteins or via <jats:italic>de novo<\/jats:italic> synthesis. In specialized cells, anabolic enzymes metabolize cholesterol, generating steroid hormones or bile acids. However, surplus cholesterol cannot be catabolized due to the lack of enzymes capable of degrading the cholestane ring. The inability to degrade cholesterol becomes evident in the development and progression of cardiovascular disease, where the accumulation of cholesterol\/cholesteryl-esters in macrophages can elicit a maladaptive immune response leading to the development and progression of atherosclerosis. The discovery of cholesterol catabolic pathways in <jats:italic>Actinomycetes<\/jats:italic> led us to the hypothesis that if enzymes enabling cholesterol catabolism could be genetically engineered and introduced into human cells, the atherosclerotic process may be prevented or reversed. Comparison of bacterial enzymes that degrade cholesterol to obtain carbon and generate energy with the action of human enzymes revealed that humans lack a 3-ketosteroid \u0394<jats:sup>1<\/jats:sup>-dehydrogenase (\u0394<jats:sup>1<\/jats:sup>-KstD), which catalyzes the C-1 and C-2 desaturation of ring A. Here we describe the construction, heterologous expression, and actions of a synthetic humanized \u0394<jats:sup>1<\/jats:sup>-KstD expressed in Hep3B and U-937 cells, providing proof that one of three key enzymes required for cholesterol ring opening can be functionally expressed in human cells.<\/jats:p>","DOI":"10.1038\/s41598-019-42046-8","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T10:02:59Z","timestamp":1555063379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of a Synthetic 3-ketosteroid\u00a0\u03941-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7030-5238","authenticated-orcid":false,"given":"Brandon M.","family":"D\u2019Arcy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Swingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Schambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Pannell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Honkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"42046_CR1","first-page":"40","volume":"7","author":"RB Singh","year":"2002","unstructured":"Singh, R. B., Mengi, S. A., Xu, Y. J., Arneja, A. S. & Dhalla, N. S. Pathogenesis of atherosclerosis: A multifactorial process. Exp Clin Cardiol 7, 40\u201353 (2002).","journal-title":"Exp Clin Cardiol"},{"key":"42046_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.beem.2014.01.005","volume":"28","author":"BA Franklin","year":"2014","unstructured":"Franklin, B. A., Durstine, J. L., Roberts, C. K. & Barnard, R. J. Impact of diet and exercise on lipid management in the modern era. Best Pract Res Clin Endocrinol Metab 28, 405\u2013421, https:\/\/doi.org\/10.1016\/j.beem.2014.01.005 (2014).","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"42046_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2014.12.001","volume":"19","author":"HH Liu","year":"2015","unstructured":"Liu, H. H. & Li, J. J. Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev 19, 43\u201352, https:\/\/doi.org\/10.1016\/j.arr.2014.12.001 (2015).","journal-title":"Ageing Res Rev"},{"key":"42046_CR4","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 137, e67\u2013e492, https:\/\/doi.org\/10.1161\/CIR.0000000000000558 (2018).","journal-title":"Circulation"},{"key":"42046_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/archinte.163.13.1549","volume":"163","author":"AW Weverling-Rijnsburger","year":"2003","unstructured":"Weverling-Rijnsburger, A. W., Jonkers, I. J., van Exel, E., Gussekloo, J. & Westendorp, R. G. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 163, 1549\u20131554, https:\/\/doi.org\/10.1001\/archinte.163.13.1549 (2003).","journal-title":"Arch Intern Med"},{"key":"42046_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang, C. C., Hess, C. N., Hiatt, W. R. & Goldfine, A. B. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation 133, 2459\u20132502, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022194 (2016).","journal-title":"Circulation"},{"key":"42046_CR7","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1210\/jc.2003-030398","volume":"88","author":"AR Cappola","year":"2003","unstructured":"Cappola, A. R. & Ladenson, P. W. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88, 2438\u20132444, https:\/\/doi.org\/10.1210\/jc.2003-030398 (2003).","journal-title":"J Clin Endocrinol Metab"},{"key":"42046_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11255-013-0407-1","volume":"45","author":"S Olechnowicz-Tietz","year":"2013","unstructured":"Olechnowicz-Tietz, S., Gluba, A., Paradowska, A., Banach, M. & Rysz, J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol 45, 1605\u20131612, https:\/\/doi.org\/10.1007\/s11255-013-0407-1 (2013).","journal-title":"Int Urol Nephrol"},{"key":"42046_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein, J. L. & Brown, M. S. A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161, 161\u2013172, https:\/\/doi.org\/10.1016\/j.cell.2015.01.036 (2015).","journal-title":"Cell"},{"key":"42046_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrg2481","volume":"10","author":"RA Hegele","year":"2009","unstructured":"Hegele, R. A. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 10, 109\u2013121, https:\/\/doi.org\/10.1038\/nrg2481 (2009).","journal-title":"Nat Rev Genet"},{"key":"42046_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0974-2069.132478","volume":"7","author":"MJ Varghese","year":"2014","unstructured":"Varghese, M. J. Familial hypercholesterolemia: A review. Ann Pediatr Cardiol 7, 107\u2013117, https:\/\/doi.org\/10.4103\/0974-2069.132478 (2014).","journal-title":"Ann Pediatr Cardiol"},{"key":"42046_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin, M. A., Hutter, C. M., Zimmern, R. L. & Humphries, S. E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160, 407\u2013420, https:\/\/doi.org\/10.1093\/aje\/kwh236 (2004).","journal-title":"Am J Epidemiol"},{"key":"42046_CR13","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","volume":"116","author":"I Tabas","year":"2007","unstructured":"Tabas, I., Williams, K. J. & Boren, J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832\u20131844, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.676890 (2007).","journal-title":"Circulation"},{"key":"42046_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0021-9150(88)90298-5","volume":"71","author":"AL Bylock","year":"1988","unstructured":"Bylock, A. L. & Gerrity, R. G. Visualization of monocyte recruitment into atherosclerotic arteries using fluorescent labelling. Atherosclerosis 71, 17\u201325 (1988).","journal-title":"Atherosclerosis"},{"key":"42046_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","volume":"27","author":"E Galkina","year":"2009","unstructured":"Galkina, E. & Ley, K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 27, 165\u2013197, https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132620 (2009).","journal-title":"Annu Rev Immunol"},{"key":"42046_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.bi.52.070183.001255","volume":"52","author":"MS Brown","year":"1983","unstructured":"Brown, M. S. & Goldstein, J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52, 223\u2013261, https:\/\/doi.org\/10.1146\/annurev.bi.52.070183.001255 (1983).","journal-title":"Annu Rev Biochem"},{"key":"42046_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm1102-1235","volume":"8","author":"AC Li","year":"2002","unstructured":"Li, A. C. & Glass, C. K. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8, 1235\u20131242, https:\/\/doi.org\/10.1038\/nm1102-1235 (2002).","journal-title":"Nat Med"},{"key":"42046_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1388-1981(00)00144-X","volume":"1529","author":"KF Buhman","year":"2000","unstructured":"Buhman, K. F., Accad, M. & Farese, R. V. Mammalian acyl-CoA:cholesterol acyltransferases. Biochim Biophys Acta 1529, 142\u2013154 (2000).","journal-title":"Biochim Biophys Acta"},{"key":"42046_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/1050-1738(94)90038-8","volume":"4","author":"TY Chang","year":"1994","unstructured":"Chang, T. Y., Chang, C. C. & Cadigan, K. M. The structure of acyl coenzyme A-cholesterol acyltransferase and its potential relevance to atherosclerosis. Trends Cardiovasc Med 4, 223\u2013230, https:\/\/doi.org\/10.1016\/1050-1738(94)90038-8 (1994).","journal-title":"Trends Cardiovasc Med"},{"key":"42046_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/01.mol.0000203192.45649.ba","volume":"17","author":"D Akopian","year":"2006","unstructured":"Akopian, D. & Medh, J. D. Genetics and molecular biology: macrophage ACAT depletion - mechanisms of atherogenesis. Curr Opin Lipidol 17, 85\u201388 (2006).","journal-title":"Curr Opin Lipidol"},{"key":"42046_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/01.ATV.0000054662.44688.9A","volume":"23","author":"JF Oram","year":"2003","unstructured":"Oram, J. F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23, 720\u2013727, https:\/\/doi.org\/10.1161\/01.ATV.0000054662.44688.9A (2003).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"42046_CR22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1161\/01.ATV.0000078520.89539.77","volume":"23","author":"RR Singaraja","year":"2003","unstructured":"Singaraja, R. R., Brunham, L. R., Visscher, H., Kastelein, J. J. & Hayden, M. R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23, 1322\u20131332, https:\/\/doi.org\/10.1161\/01.ATV.0000078520.89539.77 (2003).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"42046_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI16391","volume":"110","author":"AR Tall","year":"2002","unstructured":"Tall, A. R., Costet, P. & Wang, N. Regulation and mechanisms of macrophage cholesterol efflux. J Clin Invest 110, 899\u2013904, https:\/\/doi.org\/10.1172\/JCI16391 (2002).","journal-title":"J Clin Invest"},{"key":"42046_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00054556","volume":"6","author":"DW Russell","year":"1992","unstructured":"Russell, D. W. Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther 6, 103\u2013110 (1992).","journal-title":"Cardiovasc Drugs Ther"},{"key":"42046_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tcb.2003.08.007","volume":"13","author":"RG Anderson","year":"2003","unstructured":"Anderson, R. G. Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends Cell Biol 13, 534\u2013539 (2003).","journal-title":"Trends Cell Biol"},{"key":"42046_CR26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.70.7.2162","volume":"70","author":"MS Brown","year":"1973","unstructured":"Brown, M. S., Dana, S. E. & Goldstein, J. L. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc Natl Acad Sci USA 70, 2162\u20132166 (1973).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42046_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown, M. S. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34\u201347 (1986).","journal-title":"Science"},{"key":"42046_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells4020178","volume":"4","author":"IA Zani","year":"2015","unstructured":"Zani, I. A. et al. Scavenger receptor structure and function in health and disease. Cells 4, 178\u2013201, https:\/\/doi.org\/10.3390\/cells4020178 (2015).","journal-title":"Cells"},{"key":"42046_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcmm.12689","volume":"20","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov, D. A., Bobryshev, Y. V. & Orekhov, A. N. Macrophage-mediated cholesterol handling in atherosclerosis. J Cell Mol Med 20, 17\u201328, https:\/\/doi.org\/10.1111\/jcmm.12689 (2016).","journal-title":"J Cell Mol Med"},{"key":"42046_CR30","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.2174\/1381612054865064","volume":"11","author":"P Shashkin","year":"2005","unstructured":"Shashkin, P., Dragulev, B. & Ley, K. Macrophage differentiation to foam cells. Curr Pharm Des 11, 3061\u20133072 (2005).","journal-title":"Curr Pharm Des"},{"key":"42046_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13, 709\u2013721, https:\/\/doi.org\/10.1038\/nri3520 (2013).","journal-title":"Nat Rev Immunol"},{"key":"42046_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell, D. W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72, 137\u2013174, https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712 (2003).","journal-title":"Annu Rev Biochem"},{"issue":"Suppl","key":"42046_CR33","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1194\/jlr.R800026-JLR200","volume":"50","author":"DW Russell","year":"2009","unstructured":"Russell, D. W. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res. 50(Suppl), S120\u2013125, https:\/\/doi.org\/10.1194\/jlr.R800026-JLR200 (2009).","journal-title":"J Lipid Res."},{"key":"42046_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/138161209787315684","volume":"15","author":"Q Zhou","year":"2009","unstructured":"Zhou, Q. & Liao, J. K. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Current pharmaceutical design 15, 467\u2013478 (2009).","journal-title":"Current pharmaceutical design"},{"key":"42046_CR35","doi-asserted-by":"crossref","unstructured":"Taylor, F. et al. Statins for the primary prevention of cardiovascular disease. The Cochrane database of systematic reviews, CD004816 (2011).","DOI":"10.1002\/14651858.CD004816.pub4"},{"key":"42046_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1083\/jcb.82.3.597","volume":"82","author":"MS Brown","year":"1979","unstructured":"Brown, M. S., Goldstein, J. L., Krieger, M., Ho, Y. K. & Anderson, R. G. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol 82, 597\u2013613 (1979).","journal-title":"J Cell Biol"},{"key":"42046_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcell.2015.00003","volume":"3","author":"JA Dubland","year":"2015","unstructured":"Dubland, J. A. & Francis, G. A. Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism. Front Cell Dev Biol 3, 3, https:\/\/doi.org\/10.3389\/fcell.2015.00003 (2015).","journal-title":"Front Cell Dev Biol"},{"key":"42046_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32, 81\u2013151, https:\/\/doi.org\/10.1210\/er.2010-0013 (2011).","journal-title":"Endocr Rev"},{"key":"42046_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/82_2012_299","volume":"374","author":"S Ehrt","year":"2013","unstructured":"Ehrt, S. & Rhee, K. Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes. Curr Top Microbiol Immunol 374, 163\u2013188, https:\/\/doi.org\/10.1007\/82_2012_299 (2013).","journal-title":"Curr Top Microbiol Immunol"},{"key":"42046_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/10409238.2014.895700","volume":"49","author":"MF Wipperman","year":"2014","unstructured":"Wipperman, M. F., Sampson, N. S. & Thomas, S. T. Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49, 269\u2013293, https:\/\/doi.org\/10.3109\/10409238.2014.895700 (2014).","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"42046_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1139\/W10-115","volume":"57","author":"KC Yam","year":"2011","unstructured":"Yam, K. C., Okamoto, S., Roberts, J. N. & Eltis, L. D. Adventures in Rhodococcus - from steroids to explosives. Can J Microbiol 57, 155\u2013168, https:\/\/doi.org\/10.1139\/W10-115 (2011).","journal-title":"Can J Microbiol"},{"key":"42046_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1128\/JB.01525-07","volume":"190","author":"Y-R Chiang","year":"2008","unstructured":"Chiang, Y.-R. et al. Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans. Journal of bacteriology 190, 905\u2013914 (2008).","journal-title":"Journal of bacteriology"},{"key":"42046_CR43","doi-asserted-by":"publisher","first-page":"35559","DOI":"10.1074\/jbc.M113.522771","volume":"288","author":"A Rohman","year":"2013","unstructured":"Rohman, A., van Oosterwijk, N., Thunnissen, A. M. & Dijkstra, B. W. Crystal structure and site-directed mutagenesis of 3-ketosteroid Delta1-dehydrogenase from Rhodococcus erythropolis SQ1 explain its catalytic mechanism. J Biol Chem 288, 35559\u201335568, https:\/\/doi.org\/10.1074\/jbc.M113.522771 (2013).","journal-title":"J Biol Chem"},{"key":"42046_CR44","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1128\/AEM.66.5.2029-2036.2000","volume":"66","author":"R Van der Geize","year":"2000","unstructured":"Van der Geize, R. et al. Targeted disruption of the kstD gene encoding a 3-ketosteroid delta(1)-dehydrogenase isoenzyme of Rhodococcus erythropolis strain SQ1. Appl Environ Microbiol 66, 2029\u20132036 (2000).","journal-title":"Appl Environ Microbiol"},{"key":"42046_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1042\/BJ20071130","volume":"410","author":"J Knol","year":"2008","unstructured":"Knol, J., Bodewits, K., Hessels, G. I., Dijkhuizen, L. & van der Geize, R. 3-Keto-5alpha-steroid Delta(1)-dehydrogenase from Rhodococcus erythropolis SQ1 and its orthologue in Mycobacterium tuberculosis H37Rv are highly specific enzymes that function in cholesterol catabolism. Biochem J 410, 339\u2013346, https:\/\/doi.org\/10.1042\/BJ20071130 (2008).","journal-title":"Biochem J"},{"key":"42046_CR46","doi-asserted-by":"crossref","unstructured":"Makin, H. L. J. & Gower, D. B. Steroid analysis. (2010).","DOI":"10.1007\/978-1-4020-9775-1"},{"key":"42046_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.2910170504","volume":"17","author":"C Sundstr\u00f6m","year":"1976","unstructured":"Sundstr\u00f6m, C. & Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U\u2010937). International journal of cancer 17, 565\u2013577 (1976).","journal-title":"International journal of cancer"},{"key":"42046_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/35085034","volume":"2","author":"DG Russell","year":"2001","unstructured":"Russell, D. G. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2, 569\u2013577, https:\/\/doi.org\/10.1038\/35085034 (2001).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"42046_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(00)80754-0","volume":"97","author":"G Ferrari","year":"1999","unstructured":"Ferrari, G., Langen, H., Naito, M. & Pieters, J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97, 435\u2013447 (1999).","journal-title":"Cell"},{"key":"42046_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrmicro749","volume":"1","author":"GR Stewart","year":"2003","unstructured":"Stewart, G. R., Robertson, B. D. & Young, D. B. Tuberculosis: a problem with persistence. Nat Rev Microbiol 1, 97\u2013105, https:\/\/doi.org\/10.1038\/nrmicro749 (2003).","journal-title":"Nat Rev Microbiol"},{"key":"42046_CR51","doi-asserted-by":"publisher","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","volume":"4","author":"P Peyron","year":"2008","unstructured":"Peyron, P. et al. Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4, e1000204, https:\/\/doi.org\/10.1371\/journal.ppat.1000204 (2008).","journal-title":"PLoS Pathog"},{"key":"42046_CR52","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1073\/pnas.0711159105","volume":"105","author":"AK Pandey","year":"2008","unstructured":"Pandey, A. K. & Sassetti, C. M. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA 105, 4376\u20134380, https:\/\/doi.org\/10.1073\/pnas.0711159105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42046_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1073\/pnas.0605728104","volume":"104","author":"R Van der Geize","year":"2007","unstructured":"Van der Geize, R. et al. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci USA 104, 1947\u20131952, https:\/\/doi.org\/10.1073\/pnas.0605728104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42046_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2012.09.028","volume":"134","author":"A Brzostek","year":"2013","unstructured":"Brzostek, A., Rumijowska-Galewicz, A., Dziadek, B., Wojcik, E. A. & Dziadek, J. ChoD and HsdD can be dispensable for cholesterol degradation in mycobacteria. J Steroid Biochem Mol Biol 134, 1\u20137, https:\/\/doi.org\/10.1016\/j.jsbmb.2012.09.028 (2013).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"42046_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/AEM.01968-07","volume":"74","author":"YR Chiang","year":"2008","unstructured":"Chiang, Y. R. et al. Cholest-4-en-3-one-delta 1-dehydrogenase, a flavoprotein catalyzing the second step in anoxic cholesterol metabolism. Appl Environ Microbiol 74, 107\u2013113, https:\/\/doi.org\/10.1128\/AEM.01968-07 (2008).","journal-title":"Appl Environ Microbiol"},{"key":"42046_CR56","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1128\/JB.00274-11","volume":"193","author":"M Petrusma","year":"2011","unstructured":"Petrusma, M., Hessels, G., Dijkhuizen, L. & van der Geize, R. Multiplicity of 3-Ketosteroid-9alpha-Hydroxylase enzymes in Rhodococcus rhodochrous DSM43269 for specific degradation of different classes of steroids. J Bacteriol 193, 3931\u20133940, https:\/\/doi.org\/10.1128\/JB.00274-11 (2011).","journal-title":"J Bacteriol"},{"key":"42046_CR57","doi-asserted-by":"publisher","first-page":"e103743","DOI":"10.1371\/journal.pone.0103743","volume":"9","author":"M Neuvonen","year":"2014","unstructured":"Neuvonen, M. et al. Enzymatic oxidation of cholesterol: properties and functional effects of cholestenone in cell membranes. PLoS One. 9, e103743, https:\/\/doi.org\/10.1371\/journal.pone.0103743 (2014).","journal-title":"PLoS One."},{"key":"42046_CR58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.tim.2011.07.009","volume":"19","author":"H Ouellet","year":"2011","unstructured":"Ouellet, H., Johnston, J. B. & de Montellano, P. R. Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends Microbiol 19, 530\u2013539, https:\/\/doi.org\/10.1016\/j.tim.2011.07.009 (2011).","journal-title":"Trends Microbiol"},{"key":"42046_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10482-014-0188-2","volume":"106","author":"M Petrusma","year":"2014","unstructured":"Petrusma, M., van der Geize, R. & Dijkhuizen, L. 3-Ketosteroid 9alpha-hydroxylase enzymes: Rieske non-heme monooxygenases essential for bacterial steroid degradation. Antonie Van Leeuwenhoek 106, 157\u2013172, https:\/\/doi.org\/10.1007\/s10482-014-0188-2 (2014).","journal-title":"Antonie Van Leeuwenhoek"},{"key":"42046_CR60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12934-014-0130-3","volume":"13","author":"CH Yeh","year":"2014","unstructured":"Yeh, C. H. et al. Deletion of the gene encoding the reductase component of 3-ketosteroid 9alpha-hydroxylase in Rhodococcus equi USA-18 disrupts sterol catabolism, leading to the accumulation of 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid and 1,4-androstadiene-3,17-dione. Microb Cell Fact 13, 130, https:\/\/doi.org\/10.1186\/s12934-014-0130-3 (2014).","journal-title":"Microb Cell Fact"},{"key":"42046_CR61","doi-asserted-by":"publisher","first-page":"40717","DOI":"10.1074\/jbc.M111.289975","volume":"286","author":"JK Capyk","year":"2011","unstructured":"Capyk, J. K., Casabon, I., Gruninger, R., Strynadka, N. C. & Eltis, L. D. Activity of 3-ketosteroid 9alpha-hydroxylase (KshAB) indicates cholesterol side chain and ring degradation occur simultaneously in Mycobacterium tuberculosis. J Biol Chem 286, 40717\u201340724, https:\/\/doi.org\/10.1074\/jbc.M111.289975 (2011).","journal-title":"J Biol Chem"},{"key":"42046_CR62","doi-asserted-by":"publisher","first-page":"e6529","DOI":"10.1371\/journal.pone.0006529","volume":"4","author":"E Campeau","year":"2009","unstructured":"Campeau, E. et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 4, e6529, https:\/\/doi.org\/10.1371\/journal.pone.0006529 (2009).","journal-title":"PLoS One."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42046-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:44:05Z","timestamp":1671266645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42046-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42046-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"11 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R. Honkanen, M. Swingle and B. D\u2019Arcy are unpaid advisors for Repair Biotechnologies, Inc. and named as inventors on a provisional patent: U.S. Provisional Application Title: enabling cholesterol catabolism in human cells Appln. No.: 62\/754,499 Filing Date: November 1, 2018 Docket No.: P278091.US.02.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5969"}}